1.
Efficacy and Cost of Molecular Identification of Clinical Mycobacterial Isolates in a Resource Limited Setting. SAARC J. Tuber. Lung Dis. HIV/AIDS [Internet]. 2017 Mar. 9 [cited 2026 Jul. 18];13(1):23-31. Available from: https://www.nepjol.info/index.php/SAARCTB/article/view/16925